Obesity
|
0.500 |
SusceptibilityMutation
|
disease |
CLINVAR |
|
|
|
Obesity
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Obesity
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|
METABOLIC SYNDROME, SUSCEPTIBILITY TO
|
0.100 |
SusceptibilityMutation
|
phenotype |
CLINVAR |
|
|
|
OBESITY, AGE AT ONSET OF
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Decreased resting energy expenditure
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Increased waist to hip ratio
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Adenoma
|
0.020 |
AlteredExpression
|
group |
BEFREE |
We examined the expression of functional growth hormone secretagogue receptors (GHS-R) in a series of 30 human pituitary adenomas-six secreting GH, three GH-PRL, six prolactin (PRL), five adrenocorticotrophic hormone (ACTH), one thyroid stimulating hormone (TSH), four gonadotroph and five non-secreting adenomas.
|
10444306 |
1999 |
Obesity
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the preproghrelin/ghrelin gene associated with obesity in humans.
|
11502844 |
2001 |
Obesity, Morbid
|
0.010 |
Biomarker
|
disease |
BEFREE |
Ghrelin and preproghrelin sequences were determined in 96 unrelated female subjects with severe obesity (mean body mass index (BMI) 42.3 +/- 3.4 kg/m(2)) and in 96 non-obese female controls (mean BMI 23.0 +/- 1.4 (kg/m2) of the Swedish Obese Subjects cohort.
|
11502844 |
2001 |
Polycystic Ovary Syndrome
|
0.070 |
AlteredExpression
|
disease |
LHGDN |
Circulating ghrelin levels in patients with polycystic ovary syndrome.
|
12364442 |
2002 |
Prader-Willi Syndrome
|
0.070 |
AlteredExpression
|
disease |
LHGDN |
Elevated plasma ghrelin levels in Prader Willi syndrome.
|
12091883 |
2002 |
Cushing Syndrome
|
0.030 |
Biomarker
|
disease |
LHGDN |
Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses.
|
12566947 |
2002 |
Prostate carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines.
|
11874717 |
2002 |
Malignant neoplasm of prostate
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines.
|
11874717 |
2002 |
Cachexia
|
0.310 |
AlteredExpression
|
phenotype |
LHGDN |
Increased plasma ghrelin level in lung cancer cachexia.
|
12576449 |
2003 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Preproghrelin Leu72Met polymorphism in patients with type 2 diabetes mellitus.
|
12974878 |
2003 |
Prader-Willi Syndrome
|
0.070 |
AlteredExpression
|
disease |
LHGDN |
Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome.
|
12519848 |
2003 |
Anorexia Nervosa
|
0.050 |
Biomarker
|
disease |
LHGDN |
Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women.
|
12519838 |
2003 |
Anorexia Nervosa
|
0.050 |
AlteredExpression
|
disease |
LHGDN |
Fasting plasma ghrelin levels in subtypes of anorexia nervosa.
|
12892652 |
2003 |
Anorexia Nervosa
|
0.050 |
Biomarker
|
disease |
LHGDN |
Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa.
|
12679456 |
2003 |
Diabetes Mellitus
|
0.020 |
Biomarker
|
group |
LHGDN |
Acute plasma glucose increase, but not early insulin response, regulates plasma ghrelin.
|
14585085 |
2003 |
Acromegaly
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy.
|
12727951 |
2003 |
Cardiovascular Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The Leu72Met polymorphism of the preproghrelin gene was not related to cardiovascular disease in type 2 diabetes mellitus patients.
|
12974878 |
2003 |
Fatty Liver
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance.
|
14671152 |
2003 |